Artennua is an optimized version of Artemisia annua – a medicinal plant used for centuries in Chinese Medicine and is the source of artemisinin, the molecule recommended by the WHO to treat malaria. Artemisinin, its derivatives, and other secondary metabolites have the potential to treat many other afflictions; however, Artemisia annua produces very low quantities of artemisinin and thus global supply is limited. At Sequentia we are scientists and social entrepreneurs; we have used natural plant biopharming methods to improve the characteristics of the Artemisia annua plant so that its benefits can be exploited.
Today, on World Entrepreneur Day, we received an amazing news: we are winners of the 23th Canary Islands Entrepreneurship Award by FYDE. The CajaCanaria Bank Foundation supporting the entrepreneurship (Fundación Canaria para la Formación y Desarrollo Empresarial de CajaCanarias) selected the finalists from different islands. The jury was composed by the General Director of the…
Tricopharming as been selected as finalist company in the Canary Islands Entrepreneurship Award by Fyde CajaCanarias. Tomorrow our CEO Luis Matías Hernández will give its pitch about Artennua, first Tricopharming product. Artennua is produced in our ecologic farm El Pico in Tejina, Tenerife Island. The project started in Tenerife in 2017 thanks to CDTI funding and…
Innovation and agriculture, medicinal plants and biotechnology, this is Tricopharming. Using biological techniques we stimulate the natural capacity of the plants trichomes to be molecules factory. A well done article titled “Biopharmaceutical Agriculture, from the laboratory to the field”, Newspaper La Vanguardia tells our story: our company, our first product and our plans for the…
